NEW YORK, March 9, 2018 /PRNewswire/ --
WallStEquities.com strives to bring the best free research to the investmentcommunity. Today we are offering reports on HIIQ, HUM, MOH, and UNH which can be accessed for free by signing up to www.wallstequities.com/registration. WallStEquities.com has initiated research coverage on Health Insurance Innovations Inc. (NASDAQ:
Health Insurance Innovations
Shares in Tampa, Florida-based Health Insurance Innovations Inc. climbed 1.15%, ending Thursday's trading session at $30.90. The stock recorded a trading volume of 271,951 shares. The Company's shares have surged 27.16% in the last month, 40.30% over the last three months, and 97.44% over the past year. The stock is trading 14.38% and 22.98% above its 50-day and 200-day moving averages, respectively. Moreover, shares of the Company, which operates as a developer, distributor, and administrator of cloud-based individual health and family insurance plans, and supplemental products in the US, have a Relative Strength Index (RSI) of 59.64.
On March 01st, 2018, research firm Raymond James upgraded the Company's stock rating from 'Market Perform' to 'Outperform'.
On March 07th, 2018, Health Insurance Innovations announced that it will present at the 30th Annual Roth Capital Growth Stock Conference in Dana Point, California. The presentation is scheduled for Tuesday, March 13th, 2018, at 11:00 a.m. PDT. Company management will be available for one-on-one meetings with institutional investors on the same day. Get the full research report on HIIQ for free by clicking below at: www.wallstequities.com/registration/?symbol=HIIQ
Louisville, Kentucky headquartered Humana Inc.'s stock declined 1.38%, closing the day at $269.52. A total volume of 1.73 million shares was traded, which was above their three months average volume of 1.11 million shares. The Company's shares have advanced 0.15% in the past month, 6.39% in the previous three months, and 23.95% over the past year. The stock is trading 0.25% and 7.86% above its 50-day and 200-day moving averages, respectively. Additionally, shares of Humana, which together with its subsidiaries, operates as a health and well-being company in the US, have an RSI of 50.31.
On February 26th, 2018, Humana announced that Bruce D. Broussard, President and Chief Executive Officer, will make a presentation to investors at the Barclays Global Healthcare Conference on Tuesday, March 13th, 2018, at 1:35 p.m. ET. A live audio webcast of the presentation will be available under Investor Relations page of the Company's website. Access the free research report on HUM now by signing up at: www.wallstequities.com/registration/?symbol=HUM
On Thursday, shares in Long Beach, California headquartered Molina Healthcare Inc. recorded a trading volume of 1.11 million shares. The stock ended the day flat at $74.75. The Company's shares have advanced 54.19% over the past year. The stock is trading above its 200-day moving average by 4.51%. Furthermore, shares of Molina Healthcare have an RSI of 44.02.
On February 26th, 2018, Molina Healthcare announced that John C. Molina has stepped down from the Board of Directors. John Molina is the son of Dr. C. David Molina, the late founder of the Company. John served as a member of the Board since 1994. Are you already registered with Wall St. Equities? Do so now for free, and get the report on MOH at: www.wallstequities.com/registration/?symbol=MOH
Minnetonka, Minnesota-based UnitedHealth Group Inc.'s stock dropped 1.12%, finishing yesterday's session at $224.73 with a total trading volume of 3.46 million shares. The Company's shares have advanced 2.11% in the previous three months and 33.84% over the past year. The stock is trading above its 200-day moving average by 9.22%. Additionally, shares of UnitedHealth, which operates as a diversified health care company in the US, have an RSI of 46.77.
On February 27th, 2018, UnitedHealthcare, one of the businesses of UnitedHealth Group, announced that it is a winner in the "Customer Service Department of the Year" category presented by the Stevie Awards, an international awards program recognizing outstanding performances in the workplace. The results were announced on Friday, February 23rd, 2018 in Las Vegas, attended by finalist organizations from across the United States and several other countries.
On March 08th, 2018, research firm Barclays initiated an 'Overweight' rating on the Company's stock, with a target price of $265 per share. Aspiring Member, please take a moment to register below for your free research report on UNH at: www.wallstequities.com/registration/?symbol=UNH
Wall St. Equities:
Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
WSE has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/
For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: email@example.com Phone number: +21-32-044-483Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
View original content:http://www.prnewswire.com/news-releases/technical-perspectives-on-health-care-plans-stocks----health-insurance-innovations-humana-molina-healthcare-and-unitedhealth-300611417.html
SOURCE Wall St. Equities
Subscribe to our Free Newsletters!
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...
DOOR syndrome is a rare genetic disorder marked by deafness, short or absent fingernails, abnormal ...View All